Vanguard Capital Management’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
Other funds holding HCWB
Vanguard Capital Management's HCWB Position: Q3 2026 in Review
Vanguard Capital Management increased its HCW Biologics (HCWB) stake by 0.1% in Q3 2026, buying an estimated $6 and bringing the position to 2,005 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4050.
Vanguard Capital Management first reported a position in HCWB in Q1 2026 and has held it in 3 quarters since. The position peaked at $10K in Q2 2026. 12 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.
- Vanguard Capital Management held 2,005 shares of HCW Biologics worth $3.43K as of Q3 2026.
- Vanguard Capital Management bought 2 HCW Biologics shares in Q3 2026, an estimated $6.
- HCW Biologics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4050 holding.
- Vanguard Capital Management first reported a position in HCW Biologics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's HCW Biologics position peaked at $10K in Q2 2026.
- 12 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.